全文获取类型
收费全文 | 455篇 |
免费 | 2篇 |
专业分类
系统科学 | 8篇 |
教育与普及 | 2篇 |
理论与方法论 | 3篇 |
现状及发展 | 39篇 |
研究方法 | 96篇 |
综合类 | 283篇 |
自然研究 | 26篇 |
出版年
2023年 | 1篇 |
2021年 | 4篇 |
2020年 | 3篇 |
2019年 | 1篇 |
2018年 | 6篇 |
2017年 | 5篇 |
2016年 | 8篇 |
2015年 | 2篇 |
2014年 | 6篇 |
2013年 | 6篇 |
2012年 | 55篇 |
2011年 | 78篇 |
2010年 | 13篇 |
2009年 | 4篇 |
2008年 | 52篇 |
2007年 | 43篇 |
2006年 | 42篇 |
2005年 | 32篇 |
2004年 | 38篇 |
2003年 | 23篇 |
2002年 | 29篇 |
2001年 | 3篇 |
1999年 | 1篇 |
1992年 | 1篇 |
1983年 | 1篇 |
排序方式: 共有457条查询结果,搜索用时 31 毫秒
281.
282.
Walker LM Huber M Doores KJ Falkowska E Pejchal R Julien JP Wang SK Ramos A Chan-Hui PY Moyle M Mitcham JL Hammond PW Olsen OA Phung P Fling S Wong CH Phogat S Wrin T Simek MD;Protocol G Principal Investigators Koff WC Wilson IA Burton DR Poignard P 《Nature》2011,477(7365):466-470
Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses. Here we probed the neutralizing antibody repertoires of four human immunodeficiency virus (HIV)-infected donors with remarkably broad and potent neutralizing responses and rescued 17 new monoclonal antibodies that neutralize broadly across clades. Many of the new monoclonal antibodies are almost tenfold more potent than the recently described PG9, PG16 and VRC01 broadly neutralizing monoclonal antibodies and 100-fold more potent than the original prototype HIV broadly neutralizing monoclonal antibodies. The monoclonal antibodies largely recapitulate the neutralization breadth found in the corresponding donor serum and many recognize novel epitopes on envelope (Env) glycoprotein gp120, illuminating new targets for vaccine design. Analysis of neutralization by the full complement of anti-HIV broadly neutralizing monoclonal antibodies now available reveals that certain combinations of antibodies should offer markedly more favourable coverage of the enormous diversity of global circulating viruses than others and these combinations might be sought in active or passive immunization regimes. Overall, the isolation of multiple HIV broadly neutralizing monoclonal antibodies from several donors that, in aggregate, provide broad coverage at low concentrations is a highly positive indicator for the eventual design of an effective antibody-based HIV vaccine. 相似文献
283.
Systemic Practice and Action Research - Experienced system dynamicists commonly conceptualise causal relationships and feedback loops using Causal Loop Diagrams (CLDs). In adhering to best... 相似文献
284.
Elias, et al.(2016) conjectured that the Kazhdan-Lusztig polynomial of any matroid is logconcave. Inspired by a computer proof of Moll’s log-concavity conjecture given by Kauers and Paule,the authors use a computer algebra system to prove the conjecture for arbitrary uniform matroids. 相似文献
285.
Krishnamurthy J Ramsey MR Ligon KL Torrice C Koh A Bonner-Weir S Sharpless NE 《Nature》2006,443(7110):453-457
286.
287.
Paton AW Beddoe T Thorpe CM Whisstock JC Wilce MC Rossjohn J Talbot UM Paton JC 《Nature》2006,443(7111):548-552
AB5 toxins are produced by pathogenic bacteria and consist of enzymatic A subunits that corrupt essential eukaryotic cell functions, and pentameric B subunits that mediate uptake into the target cell. AB5 toxins include the Shiga, cholera and pertussis toxins and a recently discovered fourth family, subtilase cytotoxin, which is produced by certain Shiga toxigenic strains of Escherichia coli. Here we show that the extreme cytotoxicity of this toxin for eukaryotic cells is due to a specific single-site cleavage of the essential endoplasmic reticulum chaperone BiP/GRP78. The A subunit is a subtilase-like serine protease; structural studies revealed an unusually deep active-site cleft, which accounts for its exquisite substrate specificity. A single amino-acid substitution in the BiP target site prevented cleavage, and co-expression of this resistant protein protected transfected cells against the toxin. BiP is a master regulator of endoplasmic reticulum function, and its cleavage by subtilase cytotoxin represents a previously unknown trigger for cell death. 相似文献
288.
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9 总被引:1,自引:0,他引:1
Krivtsov AV Twomey D Feng Z Stubbs MC Wang Y Faber J Levine JE Wang J Hahn WC Gilliland DG Golub TR Armstrong SA 《Nature》2006,442(7104):818-822
Leukaemias and other cancers possess a rare population of cells capable of the limitless self-renewal necessary for cancer initiation and maintenance. Eradication of these cancer stem cells is probably a critical part of any successful anti-cancer therapy, and may explain why conventional cancer therapies are often effective in reducing tumour burden, but are only rarely curative. Given that both normal and cancer stem cells are capable of self-renewal, the extent to which cancer stem cells resemble normal tissue stem cells is a critical issue if targeted therapies are to be developed. However, it remains unclear whether cancer stem cells must be phenotypically similar to normal tissue stem cells or whether they can retain the identity of committed progenitors. Here we show that leukaemia stem cells (LSC) can maintain the global identity of the progenitor from which they arose while activating a limited stem-cell- or self-renewal-associated programme. We isolated LSC from leukaemias initiated in committed granulocyte macrophage progenitors through introduction of the MLL-AF9 fusion protein encoded by the t(9;11)(p22;q23). The LSC were capable of transferring leukaemia to secondary recipient mice when only four cells were transferred, and possessed an immunophenotype and global gene expression profile very similar to that of normal granulocyte macrophage progenitors. However, a subset of genes highly expressed in normal haematopoietic stem cells was re-activated in LSC. LSC can thus be generated from committed progenitors without widespread reprogramming of gene expression, and a leukaemia self-renewal-associated signature is activated in the process. Our findings define progression from normal progenitor to cancer stem cell, and suggest that targeting a self-renewal programme expressed in an abnormal context may be possible. 相似文献
289.
Matsushita H Vesely MD Koboldt DC Rickert CG Uppaluri R Magrini VJ Arthur CD White JM Chen YS Shea LK Hundal J Wendl MC Demeter R Wylie T Allison JP Smyth MJ Old LJ Mardis ER Schreiber RD 《Nature》2012,482(7385):400-404
Cancer immunoediting, the process by which the immune system controls tumour outgrowth and shapes tumour immunogenicity, is comprised of three phases: elimination, equilibrium and escape. Although many immune components that participate in this process are known, its underlying mechanisms remain poorly defined. A central tenet of cancer immunoediting is that T-cell recognition of tumour antigens drives the immunological destruction or sculpting of a developing cancer. However, our current understanding of tumour antigens comes largely from analyses of cancers that develop in immunocompetent hosts and thus may have already been edited. Little is known about the antigens expressed in nascent tumour cells, whether they are sufficient to induce protective antitumour immune responses or whether their expression is modulated by the immune system. Here, using massively parallel sequencing, we characterize expressed mutations in highly immunogenic methylcholanthrene-induced sarcomas derived from immunodeficient Rag2(-/-) mice that phenotypically resemble nascent primary tumour cells. Using class I prediction algorithms, we identify mutant spectrin-β2 as a potential rejection antigen of the d42m1 sarcoma and validate this prediction by conventional antigen expression cloning and detection. We also demonstrate that cancer immunoediting of d42m1 occurs via a T-cell-dependent immunoselection process that promotes outgrowth of pre-existing tumour cell clones lacking highly antigenic mutant spectrin-β2 and other potential strong antigens. These results demonstrate that the strong immunogenicity of an unedited tumour can be ascribed to expression of highly antigenic mutant proteins and show that outgrowth of tumour cells that lack these strong antigens via a T-cell-dependent immunoselection process represents one mechanism of cancer immunoediting. 相似文献
290.
Over a two-year period, Voyager 1 observed a gradual slowing-down of radial plasma flow in the heliosheath to near-zero velocity after April 2010 at a distance of 113.5 astronomical units from the Sun (1 astronomical unit equals 1.5?×?10(8) kilometres). Voyager 1 was then about 20 astronomical units beyond the shock that terminates the free expansion of the solar wind and was immersed in the heated non-thermal plasma region called the heliosheath. The expectation from contemporary simulations was that the heliosheath plasma would be deflected from radial flow to meridional flow (in solar heliospheric coordinates), which at Voyager?1 would lie mainly on the (locally spherical) surface called the heliopause. This surface is supposed to separate the heliosheath plasma, which is of solar origin, from the interstellar plasma, which is of local Galactic origin. In 2011, the Voyager project began occasional temporary re-orientations of the spacecraft (totalling about 10-25 hours every 2 months) to re-align the Low-Energy Charged Particle instrument on board Voyager?1 so that it could measure meridional flow. Here we report that, contrary to expectations, these observations yielded a meridional flow velocity of +3?±?11?km?s(-1), that is, one consistent with zero within statistical uncertainties. 相似文献